- Net sales grew 5% (cc[1], +7% USD) mainly driven by:
- Cosentyx grew to USD 701 million, (+40% cc) with strong growth in all indications in the US and EU
- Entresto sales more than doubled to USD 239 million, (+113% cc) driven by continued uptake worldwide
- Oncology grew 10% (cc) driven by continued growth from Promacta/Revolade, Tafinlar + Mekinist and Jakavi, uptake of Kisqali and Kymriah and contribution from the AAA acquisition
- Core[ …
- Net sales grew 5% (cc[1], +7% USD) mainly driven by:
- Cosentyx grew to USD 701 million, (+40% cc) with strong growth in all indications in the US and EU
- Entresto sales more than doubled to USD 239 million, (+113% cc) driven by continued uptake worldwide
- Oncology grew 10% (cc) driven by continued growth from Promacta/Revolade, Tafinlar + Mekinist and Jakavi, uptake of Kisqali and Kymriah and contribution from the AAA acquisition
- Core[ …
Follow us on Facebook
ADDRESS – ZIMBABWE
Suite 204, Block 1
Long Cheng Plaza
Mutley Bend, Belvedere
Harare, Zimbabwe
ADDRESS – ZAMBIA
Plot 43504
Apex Chalala
Off Kasama Road
Lusaka Zambia